An Updated Approach to the Diagnosis and Treatment of Enteric Fever for Healthcare Professionals
OthersPage Navigation
Introduction
Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant global health concern. The complexity of diagnosis and evolving resistance patterns necessitate updated approaches for healthcare professionals.
Diagnostic Advances
Traditional culture methods, though gold standard, have limitations in sensitivity and speed. Recent advancements include serologic tests like Typhidot and Tubex TF, offering quicker results. However, their variable sensitivity and specificity necessitate cautious interpretation. Molecular diagnostic methods, such as PCR, show promise with high sensitivity and specificity, but require further validation.
Treatment Updates
Antimicrobial resistance complicates treatment. Fluoroquinolones, previously first-line, are now less effective due to widespread resistance. Current WHO guidelines recommend empirical treatment with ceftriaxone or azithromycin. Vaccination, though not 100% effective, remains an important preventive measure, especially in endemic areas.
Role of Healthcare Professionals
Healthcare professionals play a critical role in diagnosing enteric fever early, initiating appropriate treatment, and preventing disease spread. Continued education about updated diagnostic methods and treatment guidelines is essential.
Conclusion
Enteric fever continues to pose significant challenges in diagnosis and treatment. Embracing new diagnostic tools, adhering to updated treatment guidelines, and promoting vaccination are key strategies in managing this global health issue. Healthcare professionals' adaptability to these changes is critical in reducing the burden of enteric fever.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
New drug combination shows good results in patients with HPV-negative head and neck cancer
2.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
3.
Asian Women With Breast Cancer Outlive White Peers
4.
What Comes After Cancer?
5.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
1.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
2.
Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine
3.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
4.
Endurance Training in Hematologic Disease: Current Perspectives and Clinical Implications
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Diagnosis and Management in Hematology
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge